Sector Focus

Biotechnology

Caliber has successfully planned with both venture backed private development stage companies and publicly traded biopharmaceutical companies. We understand the unique challenges of emerging companies as well as global biotech organizations and we have developed a keen sense of what it takes to discover and develop biologically derived treatments to enhance the quality of care in markets with substantially under met medical needs.

Clients

PaxVax, Inc.

PaxVax is a development stage vaccine company with a mission to develop and commercialize both innovative and socially responsible vaccines against infectious diseases for global impact.

Search Projects

  • Executive Vice President and Chief Operating Officer
  • Executive Vice President and Chief Scientific Officer